- Lead Author to download the TAM Clinical Guideline Checklist (CGC) and Guideline Template Right click the link and copy and paste into a new browser window for the form to open).
These give a standardised guidance structure and good governance for the author to follow.
- Working group involvement
It is recommended that guidance is developed collaboratively with multidisciplinary, cross-sector and multiagency involvement. A suggested working group membership is given in the CGC.
- Guidance style
All guidance will be transposed onto the TAM software templates, including in-house flowcharts. Simply prepared guidance is appropriate, such as Word/PowerPoint, and it should remain editable.
- Guidance finalisation
Guidance is to be finalised within the Clinical Department prior to submission as per the approval section of the CGC. The TAM subgroup will not accept or comment on draft guidance.
Submit the finalised guidance and its completed CGC to firstname.lastname@example.org
- TAM subgroup responses
The subgroup will advise the Lead Author:
- REJECTION: major amendments will be suggested - Guidance to be resubmitted.
- ACCEPTANCE PENDING: minor amendments will be suggested – Guidance can be published after these have been actioned. No further submission required.
- ACCEPTANCE: Guidance is suitable for uploading to TAM.
- Guidance upload to TAM
Accepted guidance is uploaded onto TAM and the Lead Author notified to accuracy check the transcription.
- Guidance review
The TAM team will contact the Lead Author 3 months before a guidance is due for review. If there is no timely response the request will be escalated to the Clinical Lead. If the guidance is allowed to remain out of date it will be discussed at the next TAM subgroup whether it should be removed, or further action recommended.
- Guidance update process
Lead Author will be sent the original guidance and its CGC. For minor changes both documents are to be track changed and resubmitted to email@example.com so that the amendments can be seen by the TAM subgroup. For major amendments it may be more appropriate to rewrite the guidance using the guidance template.
- Further information and support
Contact the TAM team at firstname.lastname@example.org
Developing guidance in NHS Highland
Revised Policy for Management of Policies, Procedures, and other Written Controlled Documents. NHS Highland’s controlled documents are subdivided into: Clinical, Organisational, Financial, Staff and eHealth. This procedure relates to clinical controlled documents (herein called [therapeutic] guidance). Therapeutic guidance can be submitted by any Health or Social Care Professional employed by NHS Highland.
Introduction to the TAM app
TAM (Treatment and Medicines) is a publicly available website and downloadable mobile app. It hosts NHS Highland’s therapeutic guidance, the Highland Formulary and ancillary formularies, patient information and links to recommended national resources. TAM is the recommended resource for point-of-care therapeutic guidance for clinicians working in North NHS Highland.
Note re Argyll and Bute: The majority of the content on TAM has been produced by and for North NHS Highland. Where guidance is produced by and for Argyll and Bute, this is stated.
- Information that is not suitable for public access, eg. forms and charts for clinical use, is available via a secure link to the forms library of the NHS Highland intranet.
- No patient identifiable information is hosted on TAM.
The TAM subgroup is a multidisciplinary, cross-sector and multiagency working group of NHS Highland’s Area Drug and Therapeutics Committee whose remit is to maintain the Highland Formulary and the TAM app for Highland Health and Social Care Partnership (HHSCP).
It meets bimonthly (subgroup dates). Guidance received up to 3 weeks prior to a subgroup will be discussed at that subgroup. If considered necessary, the Lead Author may attend to present the guidance.